BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Director Amy E Mckee sold $54K of BioCryst Pharmaceuticals, Inc.
Sold$54,352
$6.32Price
8,600Shares
−24%Stake
What BCRX did after the filing
- The stock from Tue, Jun 25 close, $6.08
- +22.4%
- S&P 500, same days
- −4.8%
Measured over 30 trading days, to the Aug 7 close.
Traded Mon, Jun 24. Filed Tue, Jun 25, 12:39 PM ET, during the session. Returns use the Jun 25 close and the Aug 7 close. Not investment advice.